Callan Family Office LLC purchased a new stake in Unifirst Corporation (NYSE:UNF – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,841 shares of the textile maker’s stock, valued at approximately $347,000.
Other institutional investors have also recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. raised its holdings in Unifirst by 474.1% in the first quarter. Geneos Wealth Management Inc. now owns 155 shares of the textile maker’s stock valued at $27,000 after acquiring an additional 128 shares in the last quarter. GAMMA Investing LLC raised its holdings in Unifirst by 59.9% in the first quarter. GAMMA Investing LLC now owns 227 shares of the textile maker’s stock valued at $39,000 after acquiring an additional 85 shares in the last quarter. Fifth Third Bancorp raised its holdings in Unifirst by 88.7% in the first quarter. Fifth Third Bancorp now owns 266 shares of the textile maker’s stock valued at $46,000 after acquiring an additional 125 shares in the last quarter. PenderFund Capital Management Ltd. acquired a new stake in Unifirst in the first quarter valued at $70,000. Finally, Vestcor Inc acquired a new stake in Unifirst in the first quarter valued at $87,000. 78.17% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several analysts recently issued reports on UNF shares. Barclays set a $152.00 price target on shares of Unifirst and gave the company an “underweight” rating in a report on Monday, June 30th. Robert W. Baird set a $197.00 target price on shares of Unifirst in a report on Monday, June 30th. JPMorgan Chase & Co. assumed coverage on shares of Unifirst in a report on Monday, July 14th. They set an “underweight” rating and a $175.00 target price on the stock. Weiss Ratings reissued a “hold (c)” rating on shares of Unifirst in a report on Wednesday, October 8th. Finally, UBS Group dropped their target price on shares of Unifirst from $196.00 to $194.00 and set a “neutral” rating on the stock in a report on Monday, June 30th. Three equities research analysts have rated the stock with a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Reduce” and an average price target of $179.50.
Unifirst Stock Down 0.9%
UNF stock opened at $161.77 on Thursday. Unifirst Corporation has a fifty-two week low of $156.21 and a fifty-two week high of $243.70. The firm’s 50-day simple moving average is $171.20 and its 200 day simple moving average is $176.28. The stock has a market cap of $3.00 billion, a PE ratio of 19.87 and a beta of 0.86.
Unifirst Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, September 26th. Shareholders of record on Friday, September 5th were paid a dividend of $0.35 per share. The ex-dividend date of this dividend was Friday, September 5th. This represents a $1.40 annualized dividend and a yield of 0.9%. Unifirst’s dividend payout ratio (DPR) is presently 17.20%.
Unifirst Company Profile
UniFirst Corporation provides workplace uniforms and protective work wear clothing in the United States, Europe, and Canada. The company operates through U.S. and Canadian Rental and Cleaning, Manufacturing, Specialty Garments Rental and Cleaning, and First Aid segments. It designs, manufactures, personalizes, rents, cleans, delivers, and sells a range of uniforms and protective clothing, including shirts, pants, jackets, coveralls, lab coats, smocks, and aprons; and specialized protective wear, such as flame resistant and high visibility garments.
Featured Articles
- Five stocks we like better than Unifirst
- What is a SEC Filing?
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Differences Between Momentum Investing and Long Term Investing
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Top Biotech Stocks: Exploring Innovation Opportunities
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding UNF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Unifirst Corporation (NYSE:UNF – Free Report).
Receive News & Ratings for Unifirst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unifirst and related companies with MarketBeat.com's FREE daily email newsletter.